Abstract
An innovative approach to perioperative antiseptic skin preparation is warranted because of potential adverse skin irritation, rare risk of serious allergic reaction, and perceived diminished clinical efficacy of current perioperative antiseptic agents. The results of a confirmatory US Food and Drug Administration (FDA) phase 3 efficacy analysis of a recently approved innovative perioperative surgical skin antiseptic agent are discussed. The microbial skin flora on abdominal and groin sites in healthy volunteers were microbiologically sampled following randomization to either ZuraGard, a 2% chlorhexidine/70% isopropyl alcohol preparation (Chloraprep), or a control vehicle (alcohol-free ZuraGard). Mean log10 reduction of colony-forming units (CFU) was assessed at 30 seconds, 10 minutes, and 6 hours. For combined groin sites (1,721 paired observations) at all time points, the mean log10 CFU reductions were significantly greater in the ZuraGard group than in the Chloraprep group (P < .02). Mean log10 CFU reductions across combined abdominal and groin sites at all time points (3,277 paired observations) were significantly greater in the ZuraGard group than in the Chloraprep group (P < .02). A confirmatory FDA phase 3 efficacy analy...Continue Reading
References
Dec 2, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·K B KirklandD J Sexton
Mar 16, 2007·Public Health Reports·R Monina KlevensDenise M Cardo
Jun 15, 2007·The Journal of Allergy and Clinical Immunology·Lene Heise GarveyBent Husum
Dec 5, 2008·Journal of the American Geriatrics Society·Keith S KayeKenneth E Schmader
Jun 25, 2010·American Journal of Surgery·Derek W MeeksLillian S Kao
Feb 15, 2011·Infectious Disease Clinics of North America·Deverick J Anderson
Jul 27, 2012·The Journal of Antimicrobial Chemotherapy·Carolyne HornerMark Wilcox
Sep 18, 2012·PloS One·Matthias Maiwald, Edwin S Y Chan
Oct 23, 2012·Surgical Infections·Todd R VogelStephen F Lowry
Jun 5, 2013·Journal of the American Geriatrics Society·Linda T LiAanand D Naik
Oct 15, 2013·American Journal of Surgery·Angela GibsonGregory Kennedy
Dec 25, 2013·Journal of the American College of Surgeons·Timo W HakkarainenUNKNOWN Surgical Care and Outcomes Assessment Program Collaborative
Mar 29, 2014·The New England Journal of Medicine·Shelley S MagillUNKNOWN Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team
Dec 3, 2014·AORN Journal·Charles E Edmiston, Maureen Spencer
Mar 12, 2015·Surgical Infections·Feroze Sidhwa, Kamal M F Itani
May 8, 2015·Journal of Anaesthesiology, Clinical Pharmacology·Eleni MokaAthina Vadalouca
May 8, 2015·Journal of Anaesthesiology, Clinical Pharmacology·Claude Abdallah
Sep 28, 2016·The Journal of Hospital Infection·G Kampf
Dec 5, 2016·Journal of the American College of Surgeons·Kristen A BanTherese M Duane
May 4, 2017·JAMA Surgery·Sandra I Berríos-TorresUNKNOWN Healthcare Infection Control Practices Advisory Committee
Jun 9, 2017·Clinical Microbiology Reviews·Deborah A WilliamsonBenjamin P Howden
Jul 22, 2017·Surgery·Elliot WakeamAlex B Haynes
Sep 28, 2017·The Lancet Infectious Diseases·Matthias Maiwald, Andreas F Widmer
Jan 16, 2019·American Journal of Infection Control·Marcia Maria BaraldiMaria Clara Padoveze
Apr 17, 2019·Antimicrobial Agents and Chemotherapy·Amin AddetiaDanielle M Zerr
Aug 7, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Christopher J CrnichTrish M Perl